Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised SBB in connection with the distribution of the shares in Neobo Fastigheter
Mandate

Vinge has advised SBB in connection with the distribution of the shares in Neobo Fastigheter

January 24, 2023 Banking and Finance Capital Markets and Public M&A Corporate Tax

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with the distribution of the shares in Neobo Fastigheter AB (publ) (”Neobo”) to the A and B shareholders in SBB. The resolution on the distribution was adopted at the Extraordinary General Meeting of SBB on 21 December 2022 and the distribution was carried out on 30 December 2022.

Neobo is a Swedish property company with its head office in Stockholm that long-term manages and refines rental properties in several locations in Sweden. The property portfolio is diversified over 40 municipalities with a total property value of SEK 15.8 billion. Residential properties account for 97 percent of the property portfolio’s market value and the remaining market value is made up of other properties.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl, Joel Magnusson, Johannes Akyol, Gabriel Chabo, Clara Sohlberg, Kristoffer Larson, Albert Wållgren, Kamyar Najmi, Victor Ericsson and Maria Schultzberg.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025